共 4 条
KRAS mutation signature in colorectal tumors significantly overlaps with the cetuximab response signature
被引:29
作者:

de Reynies, Aurelien
论文数: 0 引用数: 0
h-index: 0
机构:
Ligue Natl Contre Canc, Paris, France Ligue Natl Contre Canc, Paris, France

Biol, Valerie
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Gustave Roussy, Villejuif, France Ligue Natl Contre Canc, Paris, France

Milano, Gerard
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Antoine Lacassagne, Nice, France Ligue Natl Contre Canc, Paris, France

Faivre, Jean
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Bourgogne, Ctr Hosp Univ Dijon, F-21004 Dijon, France Ligue Natl Contre Canc, Paris, France

Laurent-Puig, Pierre
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Paris 05, AP HP, Inst Natl St Rech Med U775, Paris, France Ligue Natl Contre Canc, Paris, France
机构:
[1] Ligue Natl Contre Canc, Paris, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Inst Antoine Lacassagne, Nice, France
[4] Univ Bourgogne, Ctr Hosp Univ Dijon, F-21004 Dijon, France
[5] Univ Paris 05, AP HP, Inst Natl St Rech Med U775, Paris, France
关键词:
D O I:
10.1200/JCO.2007.15.9186
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
引用
收藏
页码:228 / 2230
页数:4
相关论文
共 4 条
- [1] KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab[J]. ANNALS OF ONCOLOGY, 2008, 19 (03) : 508 - 515De Roock, W.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumPiessevaux, H.论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Louvain, Clin Univ St Luc, Serv Gastroenterol, Brussels, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumDe Schutter, J.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumJanssens, M.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumDe Hertogh, G.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Morphol & Mol Pathol, Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumPersoneni, N.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumBiesmans, B.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumVan Laethem, J. -L.论文数: 0 引用数: 0 h-index: 0机构: Univ Libre Bruxelles, Erasme Univ Hosp, Gastrointestinal Canc Unit, Dept Gastroenterol, Brussels, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumPeeters, M.论文数: 0 引用数: 0 h-index: 0机构: Ghent Univ Hosp, Digest Oncol Unit, B-9000 Ghent, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumHumblet, Y.论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Clin Pathol Tumorales Colon & Rectum, Brussels, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, BelgiumTejpar, S.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium
- [2] Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy[J]. BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1166 - 1169Di Fiore, F.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, France Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceBlanchard, F.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceCharbonnier, F.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceLe Pessot, F.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceLamy, A.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceGalais, M. P.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceBastit, L.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceKillian, A.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceSesboue, R.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceTuech, J. J.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceQueuniet, A. M.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FrancePaillot, B.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceSabourin, J. C.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceMichot, F.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceMichel, P.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, FranceFrebourg, T.论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, NW Canceropole, France
- [3] Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3230 - 3237Khambata-Ford, Shirin论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAGarrett, Christopher R.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAMeropol, Neal J.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USABasik, Mark论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAHarbison, Christopher T.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAWu, Shujian论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAWong, Tai W.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAHuang, Xin论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USATakimoto, Chris H.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAGodwin, Andrew K.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USATan, Benjamin R.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAKrishnamurthi, Smitha S.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USABurris, Howard A., III论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAPoplin, Elizabeth A.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAHidalgo, Manuel论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USABaselga, Jose论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAClark, Edwin A.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USAMauro, David J.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
- [4] KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer[J]. CANCER RESEARCH, 2006, 66 (08) : 3992 - 3995Lièvre, A论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceBachet, JB论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceLe Corre, D论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceBoige, V论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceLandi, B论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceEmile, JF论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceCôté, JF论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceTomasic, G论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FrancePenna, C论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceDucreux, M论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceRougier, P论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FrancePenault-Llorca, F论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, FranceLaurent-Puig, P论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR 775, F-75006 Paris, France